Ken is a pharma executive and scientist with a passion to bring novel therapeutics and cures to patients suffering from viral and bacterial diseases. He is currently VP and Global Head of Infectious Disease Discovery at Roche Pharma Research and Early Development (pRED) in Basel, Switzerland. Prior to joining Roche in 2015, Ken was Professor of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles and director of the Molecular Screening Shared Resource (MSSR) at the California NanoSystems Institute. He obtained his PhD in Microbiology and Molecular Genetics from Harvard Medical School and was a recipient of the Bernard N. Fields Prize.